Biofrontera Inc. Other Accrued Liabilities, Current
Biofrontera Inc. (BFRI) had Other Accrued Liabilities, Current of $217.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Accrued Liabilities, Current $217.00K.
- 2026-03-31: Other Accrued Liabilities, Current $364.00K.
- 2025-12-31: Other Accrued Liabilities, Current $320.00K.
- 2025-09-30: Other Accrued Liabilities, Current $681.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $217.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $364.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $320.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $681.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $683.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $600.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $613.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $662.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $599.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $459.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $568.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $676.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $511.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $514.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $332.00K 10-K · filed 2024-03-15 | $372.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $538.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $496.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $727.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $829.00K 8-K · filed 2023-10-03 | |
| 2021-09-30 | $884.00K 10-Q · filed 2021-11-30 | |
| 2020-12-31 | $569.00K 10-K · filed 2022-04-11 | $428.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |